:

Wei Yang1, Chenglin Liu1, Zhenhua Li2,3

  • 1College of Traditional Chinese Medicine, Changchun University of Chinese Medicine, 1035 Boshuo Road, Changchun, China.

Scientific reports
|March 20, 2025
PubMed
概括

门德尔随机化确定了EVI5,OGA和TNFRSF14作为多发性硬化症 (MS) 的潜在治疗标. 这项研究为开发新型多发性硬化症免疫疗法和向治疗提供了基础.